Seer non-compliant with Nasdaq Audit Committee rule after annual meeting; cure period sought

Seer, Inc.

On July 7, 2025, notified Nasdaq that post-annual meeting it will not comply with Rule 5605(c)(2)(A) requiring at least three Audit Committee members, one with financial sophistication.
Intends to rely on cure period under Rule 5605(c)(4)(B) and expects to regain compliance before expiration.
Annual meeting elected all six director nominees: Farokhzad, Gulyani, McGuire, Langer, Nishar, Roelofs (withheld votes ranged from 0.6M to 10.0M).
Stockholders ratified Deloitte & Touche as independent auditor for FY2025 with 85.9M votes for, 4,444 against.

item 3.01item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.